End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.2 CNY | +1.06% | +2.36% | +3.61% |
Apr. 17 | Zhejiang Huahai Pharmaceutical Gets Chinese Registration Nod for Torsemide Tablets | MT |
Apr. 16 | Zhejiang Huahai Pharmaceutical Forecasts Up to 65% Rise in Q1 Profit | MT |
Sales 2023 * | 8.47B 1.17B | Sales 2024 * | 9.84B 1.36B | Capitalization | 22.37B 3.09B |
---|---|---|---|---|---|
Net income 2023 * | 978M 135M | Net income 2024 * | 1.18B 162M | EV / Sales 2023 | - |
Net Debt 2023 * | 1.9B 262M | Net Debt 2024 * | 2.54B 350M | EV / Sales 2024 * | 2.53 x |
P/E ratio 2023 * |
22.5
x | P/E ratio 2024 * |
18.8
x | Employees | 7,682 |
Yield 2023 * |
1.6% | Yield 2024 * |
1.12% | Free-Float | 56.44% |
1 day | +1.06% | ||
1 week | +2.36% | ||
Current month | +17.83% | ||
1 month | +10.71% | ||
3 months | +17.65% | ||
6 months | -4.34% | ||
Current year | +3.61% |
Managers | Title | Age | Since |
---|---|---|---|
Mei Zhang
DFI | Director of Finance/CFO | 48 | 08-05-31 |
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Si Jia Guo
BRD | Director/Board Member | 61 | 17-04-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Yong Hua Zhu
BRD | Director/Board Member | 59 | - |
Hu Gen Wang
CHM | Chairman | 75 | 10-04-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.57% | 2 M€ | -20.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 15.2 | +1.06% | 12,975,610 |
24-04-18 | 15.04 | -0.79% | 14,494,400 |
24-04-17 | 15.16 | +2.71% | 24,144,260 |
24-04-16 | 14.76 | -0.27% | 29,754,220 |
24-04-15 | 14.8 | -0.34% | 21,093,410 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.61% | 3.09B | |
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.69% | 147B | |
-6.63% | 144B |
- Stock Market
- Equities
- 600521 Stock